Statistical method for evaluation of dissolution stability in the formulation development of solid dosage forms: tablets of amonafide.
A statistical method for the evaluation of the dissolution stability results and for selecting the most stable formulation within a solid dosage form development is discussed. Three types of tablets of an antineoplastic drug, amonafide, stored at a relative humidities (RH), 45% and 75%, were used. The drug release from tablets was tested before and after storage. The experimental data were statistically fitted to empirical model equations. Furthermore, the best mathematical fit was the statistical comparison of the residuals. From the selected model equation, time-dependent dissolution (Q45 and DE45) and dissolved quantity-dependent parameters (t70, t100 and MDT) were calculated. A useful parameter to present and evaluate the results obtained in comparative stability studies was defined: the Modification Factor (MF). It allowed the selection of the most stable formulation in the easiest and fastest way: the most stable formulation should present the smallest modification of the studied characteristics, in other words, the smallest MF value. In this way, tablets II (manufactured by wet granulation and with Emcompress as main excipient) showed the greater dissolution stability of the three types of tablets studied. Amonafide tablets must be packaged in impermeable containers, since the environmental relative humidity strongly modifies their dissolution characteristics.
Gil-Alegre
M E
ME
Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, Complutense University of Madrid, Spain. galaaaa@farm.ucm.es
Bernabeu
J A
JA
Camacho
M A
MA
Torres-Suarez
A I
AI
D000225:Adenine; D000465:Algorithms; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002626:Chemistry, Pharmaceutical; D007094:Imides / Q000008:administration & dosage*; D007546:Isoquinolines / Q000008:administration & dosage*; D015233:Models, Statistical; D053644:Naphthalimides; D063065:Organophosphonates; D012995:Solubility; D013056:Spectrophotometry, Ultraviolet; D013607:Tablets
D000970:Antineoplastic Agents; D007094:Imides; D007546:Isoquinolines; D053644:Naphthalimides; D063065:Organophosphonates; D013607:Tablets; C037020:amonafide; D000225:Adenine